药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Potassium cation
Edivoxetine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Edivoxetine.
Potassium cation
Lofentanil
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Lofentanil.
Potassium cation
Dosulepin
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Dosulepin.
Potassium cation
Etizolam
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Etizolam.
Potassium cation
Brexpiprazole
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Brexpiprazole.
Potassium cation
Eslicarbazepine acetate
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Eslicarbazepine acetate.
Potassium cation
Stiripentol
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Stiripentol.
Potassium cation
Tasimelteon
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Tasimelteon.
Potassium cation
Vortioxetine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Vortioxetine.
Potassium cation
Benactyzine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Benactyzine.
Potassium cation
Benzoctamine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Benzoctamine.
Potassium cation
Brotizolam
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Brotizolam.
Potassium cation
Butriptyline
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Butriptyline.
Potassium cation
Captodiame
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Captodiame.
Potassium cation
Beclamide
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Beclamide.
Potassium cation
Barbexaclone
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Barbexaclone.
Potassium cation
Cyamemazine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Cyamemazine.
Potassium cation
Dimetacrine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Dimetacrine.
Potassium cation
Eperisone
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Eperisone.
Potassium cation
Etifoxine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Etifoxine.